France Platelet Rich Plasma (prp) Market Size & Outlook
France platelet rich plasma (prp) market, 2018-2030 (US$M)
Related Markets
France platelet rich plasma (prp) market highlights
- The France platelet rich plasma (prp) market generated a revenue of USD 27.1 million in 2023 and is expected to reach USD 73.9 million by 2030.
- The France market is expected to grow at a CAGR of 15.4% from 2024 to 2030.
- In terms of segment, pure prp was the largest revenue generating type in 2023.
- Leukocyte Rich PRP is the most lucrative type segment registering the fastest growth during the forecast period.
Platelet rich plasma (prp) market data book summary
| Market revenue in 2023 | USD 27.1 million |
| Market revenue in 2030 | USD 73.9 million |
| Growth rate | 15.4% (CAGR from 2023 to 2030) |
| Largest segment | Pure prp |
| Fastest growing segment | Leukocyte Rich PRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pure PRP, Leukocyte Rich PRP |
| Key market players worldwide | Johnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences |
Other key industry trends
- In terms of revenue, France accounted for 4.2% of the global platelet rich plasma (prp) market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK platelet rich plasma (prp) market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 123.0 million by 2030.
Pure prp was the largest segment with a revenue share of 51.66% in 2023. Horizon Databook has segmented the France platelet rich plasma (prp) market based on pure prp, leukocyte rich prp covering the revenue growth of each sub-segment from 2018 to 2030.
The French market for PRP therapy is witnessing a surge in growth opportunities driven by several key factors. There is a noticeable increase in chronic wounds and diabetic ulcers, a trend associated with the expanding aging population and the growing number of surgical procedures.
The prevalence of diabetes in France is of particular concern, standing at 8.6% according to 2021 data from the International Diabetes Federation, which translates to approximately 3,942,900 cases. This substantial diabetic population suggests a likelihood of a surge in diabetes-related ulcers and wounds.
As a result, the demand for PRP therapy in France, especially for diabetic foot ulcers, is expected to rise significantly. PRP has shown promise in enhancing wound healing, making it a valuable treatment option for healthcare providers.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Platelet Rich Plasma (PRP) Market Scope
Platelet Rich Plasma (PRP) Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France platelet rich plasma (prp) market size, by type, 2018-2030 (US$M)
France Platelet Rich Plasma (PRP) Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
